M. Holmes

发表

The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer

Richard Edlin, Ross Lawrenson, Peter Gilling, 2017, BMC Cancer.

The costs of identifying undiagnosed prostate cancer in asymptomatic men in New Zealand general practice.

R. Edlin, R. Lawrenson, P. Gilling, 2013, Family practice.

Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand

N. Scott, R. Lawrenson, Z. Obertová, 2014, BMC Family Practice.

Management and Characteristics of Patients with Metastatic Prostate Cancer in a Cohort of New Zealand Men

N. Scott, R. Lawrenson, P. Fong, 2014, Oncology.

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer

N. Scott, R. Lawrenson, P. Fong, 2014, Journal of Cancer.

Prostate cancer incidence and mortality in rural men--a systematic review of the literature.

R. Lawrenson, Z. Obertová, Charis Brown, 2012, Rural and remote health.

The patient perspective on a first raised PSA test.

R. Lawrenson, Z. Obertová, Charis Brown, 2015, Journal of primary health care.

Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis

L. Ferguson, L. Plank, R. Lawrenson, 2021, Scientific Reports.

Thick vs thin loop transurethral resection of the prostate: a double‐blind prospective trial of early morbidity

M. Holmes, P. Bary, J. Cox, 2002, BJU international.

Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study

L. Ferguson, L. Plank, R. Lawrenson, 2017, Clinical Medicine Insights. Oncology.

Hematuria and death secondary to aortoureteric fistula.

M. Holmes, N. Hung, M. Hunter, 1998, Urology.

Flexible cystoscopy: is the volume and content of the urethral gel critical?

M. Holmes, J. Stewart, M. Rice, 2001, Journal of endourology.

Role of β-microseminoprotein from prostate cancer initiation to recurrence: A mini-review

L. Ferguson, J. Masters, Shuotun Zhu, 2014 .

Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches.

M. Roberts, K. Naber, P. Harris, 2017, Urology.

Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

L. Ferguson, J. Keogh, J. Masters, 2016, BMC Urology.

Treatment modalities for Māori and New Zealand European men with localised prostate cancer

N. Scott, R. Lawrenson, P. Gilling, 2015, International Journal of Clinical Oncology.

Transurethral needle ablation of the prostate: outcome at 1 year.

M. Holmes, R. Chambers, J. Stewart, 1999, Journal of endourology.

Differences in survival between Māori and New Zealand Europeans with prostate cancer.

R. Edlin, N. Scott, R. Lawrenson, 2016, European journal of cancer care.